Amaroq Therapeutics

Amaroq Therapeutics is a biotechnology company based in Dunedin that focuses on developing a new therapy targeting cancer lncRNA. Long non-coding RNAs (lncRNAs) are a recently discovered class of molecules, often referred to as the "dark matter" of the human genome. These naturally occurring molecules do not encode proteins but play crucial regulatory roles in cells and can serve as a novel therapeutic approach for various indications. The research team at Amaroq has identified that certain lncRNA molecules are highly expressed in cancer cells, and when removed, the growth of cancer cells slows down. Amaroq Therapeutics is developing innovative cancer treatments that target lncRNAs.